obesity drug news today glp-1 october 21 2025 Weight-Loss Drugs Ride Health, Wellness Wave The popularity of GLP-1 drugs

Recent studies have shown that patients on high-dose semaglutide can lose an average of 15% to 20% of their body weight, a level previously achievable only with bariatric surgery

95% CI: 3.39, 2.77), although subgroup analysis based on formulation and dosage was not conducted

Do Results Differ Between Diabetic And Nondiabetic Patients

We combine the efficacy of prescription treatments like Wegovy (semaglutide) and Zepbound/Mounjaro (tirzepatide) with a complete free virtual consultation to tailor a regimen that supports both your medical and lifestyle needs

Why Supplementation Matters with GLP-1 When taking GLP-1 medications, its essential to consider the potential nutritional gaps that might arise

Methods Data sources and search strategy We comprehensively searched PubMed and Embase to find relevant randomized controlled trials (RCTs) from inception to June 2019 that evaluated the effect of GLP-1 receptor agonists on cardiovascular events in patients with T2DM